Application Nr Approved Date Route Status External Links
ANDA206151 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Abacavir And Lamivudine Tablets, In Combination With Other Antiretroviral Agents, Are Indicated For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection. Abacavir And Lamivudine Tablets, A Combination Of Abacavir And Lamivudine, Both Nucleoside Analogue Hiv-1 Reverse Transcriptase Inhibitors, Are Indicated In Combination With Other Antiretroviral Agents For The Treatment Of Hiv-1 Infection. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Abacavir Sulfate ABACAVIR SULFATE ZINC2015928
2. Lamivudine LAMIVUDINE ZINC12346

Comments